Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 304,000 | 374,000 | +70,000 | $12.08M | $28.23M | 9.15% | +$16.15M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 1,700,000 | 1,750,000 | +50,000 | $23.10M | $21.14M | 6.85% | -$1.96M |
| Zura Bio LimitedCL A(ZURA) | 3,815,930 | 3,815,930 | 0 | $16.52M | $20.00M | 6.48% | +$3.47M |
| Disc Medicine, Inc.(IRON) | 0 | 250,000 | +250,000 | $0 | $19.85M | 6.44% | +$19.85M |
| Rapt Therapeutics Inc | 0 | 581,187 | +581,187 | $0 | $19.68M | 6.38% | +$19.68M |
| Immunovant, Inc.(IMVT) | 500,000 | 750,000 | +250,000 | $8.06M | $19.07M | 6.18% | +$11.01M |
| Soleno Therapeutics Inc | 225,000 | 400,000 | +175,000 | $15.21M | $18.52M | 6.00% | +$3.31M |
| Vor Biopharma Inc.(VOR) | 0 | 1,370,107 | +1,370,107 | $0 | $17.92M | 5.81% | +$17.92M |
| Dianthus Therapeutics, Inc.(DNTH) | 265,803 | 350,000 | +84,197 | $10.46M | $14.42M | 4.68% | +$3.96M |
| Jade Biosciences Inc | 632,599 | 806,273 | +173,674 | $5.46M | $12.44M | 4.03% | +$6.98M |
| Kalvista Pharmaceuticals Inc | 0 | 685,632 | +685,632 | $0 | $11.07M | 3.59% | +$11.07M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 800,000 | +800,000 | $0 | $9.14M | 2.96% | +$9.14M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 1,200,000 | 1,200,000 | 0 | $7.08M | $9.06M | 2.94% | +$1.98M |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 800,000 | +800,000 | $0 | $9.05M | 2.93% | +$9.05M |
| Nektar Therapeutics(NKTR) | 300,000 | 210,732 | -89,268 | $17.07M | $8.91M | 2.89% | -$8.16M |
| Upstream Bio, Inc.(UPB) | 300,000 | 300,000 | 0 | $5.64M | $8.14M | 2.64% | +$2.50M |
| Neurogene Inc.(NGNE) | 446,814 | 350,000 | -96,814 | $7.74M | $7.21M | 2.34% | -$533.3K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 300,000 | +300,000 | $0 | $6.90M | 2.24% | +$6.90M |
| Context Therapeutics Inc.(CNTX) | 4,683,711 | 4,683,711 | 0 | $4.54M | $6.89M | 2.23% | +$2.35M |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 634,032 | +634,032 | $0 | $6.56M | 2.13% | +$6.56M |
| Evommune, Inc.(EVMN) | 0 | 325,000 | +325,000 | $0 | $5.56M | 1.80% | +$5.56M |
| Oruka Therapeutics, Inc.(ORKA) | 183,330 | 183,330 | 0 | $3.53M | $5.56M | 1.80% | +$2.03M |
| Silence Therapeutics plcADS(SLN) | 0 | 808,032 | +808,032 | $0 | $4.91M | 1.59% | +$4.91M |
| Unicycive Therapeutics, Inc.(UNCY) | 796,558 | 796,558 | 0 | $3.47M | $4.60M | 1.49% | +$1.12M |
| Climb Bio, Inc.(CLYM) | 0 | 979,534 | +979,534 | $0 | $3.92M | 1.27% | +$3.92M |
| Sana Biotechnology, Inc.(SANA) | 700,000 | 700,000 | 0 | $2.48M | $2.85M | 0.92% | +$364.0K |
| Pharvaris N V COM | 155,105 | 82,800 | -72,305 | $3.87M | $2.30M | 0.75% | -$1.57M |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 124,666 | +124,666 | $0 | $2.26M | 0.73% | +$2.26M |
| Rezolute, Inc.(RZLT) | 2,451,809 | 951,809 | -1,500,000 | $23.05M | $2.25M | 0.73% | -$20.80M |
| Absci Corporation | 796,438 | 0 | -796,438 | $2.42M | $0 | — | -$2.42M |
| ABIVAX Société Anonyme(ABVX) | 150,000 | 0 | -150,000 | $12.73M | $0 | — | -$12.73M |
| Akero Therapeutics Inc | 103,848 | 0 | -103,848 | $4.93M | $0 | — | -$4.93M |
| Ascendis Pharma A/S(ASND) | 75,000 | 0 | -75,000 | $14.91M | $0 | — | -$14.91M |
| Cytokinetics, Incorporated(CYTK) | 150,000 | 0 | -150,000 | $8.24M | $0 | — | -$8.24M |
| DBV Technologies S.A.(DBVT) | 378,594 | 0 | -378,594 | $3.79M | $0 | — | -$3.79M |
| Ionis Pharmaceuticals, Inc.(IONS) | 80,000 | 0 | -80,000 | $5.23M | $0 | — | -$5.23M |
| Legend Biotech Corporation(LEGN) | 113,460 | 0 | -113,460 | $3.70M | $0 | — | -$3.70M |
| Pliant Therapeutics, Inc.(PLRX) | 850,000 | 0 | -850,000 | $1.26M | $0 | — | -$1.26M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,500,000 | 0 | -1,500,000 | $4.91M | $0 | — | -$4.91M |
| Xenon Pharmaceuticals Inc.(XENE) | 200,000 | 0 | -200,000 | $8.03M | $0 | — | -$8.03M |